XORTX Therapeutics Inc. (XRTX) Q1 2024 Earnings
XRTX·Reported May 15, 2024·Before market open
Diluted EPS came in at $-1.24, missed the $-0.45 consensus by $0.79.
Diluted EPS
$-1.24missed by $0.79
Consensus: $-0.45
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q1 2024 Earnings FAQ
Common questions about XORTX Therapeutics Inc.'s Q1 2024 earnings report.
XORTX Therapeutics Inc. (XRTX) reported Q1 2024 earnings on May 15, 2024 before market open.
XORTX Therapeutics Inc. reported diluted EPS of $-1.24 for Q1 2024.
EPS missed the consensus estimate of $-0.45 by $0.79.